Literature DB >> 17506796

A 6-year review of surgical morbidity and oncological outcome after high anterior resection for colorectal malignancy with and without splenic flexure mobilization.

M Katory1, C L Tang, W L Koh, S M C Fook-Chong, T T Loi, B S Ooi, K S Ho, K W Eu.   

Abstract

OBJECTIVE: High anterior resection (HAR) for colorectal cancer is traditionally performed with routine mobilization of the splenic flexure. This is a retrospective review of mortality and morbidity following HAR in which the splenic flexure has been preserved.
METHOD: From a prospective database, all patients who had undergone elective HAR for colorectal cancer between 1999 and 2005 were identified. Morbidity, mortality, pathology and survival data for patients having HAR with and without splenic flexure mobilization were analysed.
RESULTS: A total of 707 patients were identified. Five hundred and thirty-one had HAR with preservation of the splenic flexure. In these patients outcome was: anastomotic leak (0.4%), wound infection (3.6%), anastomotic stricture (0.4%) and 30-day mortality (0.9%). No statistical significant difference was found for postoperative morbidity (P = 0.1926), 30-day mortality (P =0.3285), lymph node harvest (P = 0.2127) or survival (P = 0.1457) compared with patients in whom the splenic flexure was mobilized. Longitudinal resection margins were greater following HAR with splenic flexure mobilization (P < 0.0001).
CONCLUSION: No morbidity, oncological or survival disadvantage in performing splenic flexure preserving HAR was found.

Entities:  

Mesh:

Year:  2007        PMID: 17506796     DOI: 10.1111/j.1463-1318.2007.01265.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  9 in total

Review 1.  The Biology of Anastomotic Healing-the Unknown Overwhelms the Known.

Authors:  Adam Lam; Brian Fleischer; John Alverdy
Journal:  J Gastrointest Surg       Date:  2020-06-10       Impact factor: 3.452

2.  Surgeons lack predictive accuracy for anastomotic leakage in gastrointestinal surgery.

Authors:  A Karliczek; N J Harlaar; C J Zeebregts; T Wiggers; P C Baas; G M van Dam
Journal:  Int J Colorectal Dis       Date:  2009-02-17       Impact factor: 2.571

3.  Controversial topics in surgery: Splenic flexure mobilisation for anterior resection performed for sigmoid and rectal cancer.

Authors:  Robin Kennedy; Ian Jenkins; Paul J Finan
Journal:  Ann R Coll Surg Engl       Date:  2008-11       Impact factor: 1.891

4.  Lengthening of the colon for low rectal anastomosis in a cadaveric study: how much can we gain?

Authors:  S Thum-umnuaysuk; A Boonyapibal; Y Y Geng; J Pattana-Arun
Journal:  Tech Coloproctol       Date:  2012-11-15       Impact factor: 3.781

5.  Laparoscopic Colorectal Surgery for Cancer: What Is the Role of Complete Mesocolic Excision and Splenic Flexure Mobilization?

Authors:  Rosario Vecchio; Salvatore Marchese; Eva Intagliata
Journal:  Indian J Surg       Date:  2017-04-09       Impact factor: 0.656

Review 6.  Is routine splenic flexure mobilization always necessary in laparotomic or laparoscopic anterior rectal resection? A systematic review and comprehensive meta-analysis.

Authors:  Fabio Rondelli; Alessandro Pasculli; Michele De Rosa; Stefano Avenia; Walter Bugiantella
Journal:  Updates Surg       Date:  2021-07-24

7.  Clinical Significance of Pelvic Peritonization in Laparoscopic Dixon Surgery.

Authors:  Zi-Kuo Wang; Jing Xu; Cong-Cong Shang; Yong-Jie Zhao; Shuai Zhang
Journal:  Chin Med J (Engl)       Date:  2018-02-05       Impact factor: 2.628

8.  How much colonic redundancy could be obtained by splenic flexure mobilization in laparoscopic anterior or low anterior resection?

Authors:  Bong-Hyeon Kye; Hyung-Jin Kim; Hyun-Sil Kim; Jun-Gi Kim; Hyeon-Min Cho
Journal:  Int J Med Sci       Date:  2014-06-09       Impact factor: 3.738

9.  The Safety of Selective Use of Splenic Flexure Mobilization in Sigmoid and Rectal Resections-Systematic Review and Meta-Analysis.

Authors:  Michał Nowakowski; Piotr Małczak; Magdalena Mizera; Mateusz Rubinkiewicz; Anna Lasek; Mateusz Wierdak; Piotr Major; Andrzej Budzyński; Michał Pędziwiatr
Journal:  J Clin Med       Date:  2018-10-27       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.